Rodden Lori A 4
4 · HARTFORD INSURANCE GROUP, INC. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Hartford (HIG) EVP Lori Rodden Receives Awards Worth $1.25M
What Happened
Lori A. Rodden, Executive Vice President of Hartford Insurance Group (HIG), was granted equity awards on February 24, 2026. The Form 4 shows (1) 8,894.265 shares reported at $140.54 per share (total reported value $1,250,000) and (2) 9,136 derivative shares reported at $0.00 (a grant of options/other equity-linked rights). Both items are reported as awards/grants (transaction code A) — not sales.
Key Details
- Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (filed within the typical 2-business-day window).
- Award 1: 8,894.265 shares @ $140.54 — reported value $1,250,000.
- Award 2 (derivative): 9,136 shares reported at $0.00 (derivative award, e.g., options or rights).
- Shares owned after transaction: not specified in the provided filing data.
- Notable footnote: F1 states one-third of the options will become exercisable on Feb 24, 2027, another third on Feb 24, 2028, and the final third on Feb 24, 2029 (vesting schedule). Other footnotes (F2–F5) in the filing describe vesting schedules for prior grants; see the full filing for details.
Context
- The derivative line is a grant (not an exercised option or a sale). The $0.00 reporting typically means a grant of options/rights rather than a cash purchase; vesting is governed by the footnote schedules.
- These are awards to an executive rather than open-market purchases or sales; awards are common for compensation and do not, by themselves, indicate an intent to buy or sell shares immediately.
Insider Transaction Report
Form 4
Rodden Lori A
Executive Vice President
Transactions
- Award
Restricted Stock Units
2026-02-24$140.54/sh+8,894.265$1,250,000→ 8,894.265 total - Award
Stock Option
[F1]2026-02-24+9,136→ 9,136 totalExercise: $140.54Exp: 2036-02-24→ Common Stock (9,136 underlying)
Holdings
- 25,391.617
Common Stock
- 30,193
Stock Option
[F2]Exercise: $69.41Exp: 2032-02-23→ Common Stock (30,193 underlying) - 26,079
Stock Option
[F3]Exercise: $78.28Exp: 2033-02-28→ Common Stock (26,079 underlying) - 11,399
Stock Option
[F4]Exercise: $95.74Exp: 2034-02-27→ Common Stock (11,399 underlying) - 9,467
Stock Option
[F5]Exercise: $116.41Exp: 2035-02-25→ Common Stock (9,467 underlying)
Footnotes (5)
- [F1]One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
- [F2]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- [F3]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
- [F4]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- [F5]One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact|2026-02-26